BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 28900986)

  • 41. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
    Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type of "High"-grade Well-Differentiated Neuroendocrine Neoplasm.
    Guadagno E; Luglio G; Iacobelli A; Borrelli G; Castaldi A; De Rosa G; Del Basso De Caro M
    Endocr Pathol; 2018 Sep; 29(3):289-293. PubMed ID: 29675587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
    Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Pommergaard HC; Hansen CP; Federspiel B; Andreassen M; Knigge U
    Curr Treat Options Oncol; 2022 Jun; 23(6):806-817. PubMed ID: 35362798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
    Kim BS; Park YS; Yook JH; Kim BS
    Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
    Klöppel G
    Visc Med; 2017 Oct; 33(5):324-330. PubMed ID: 29177160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Sorbye H; Elvebakken H; Perren A; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Ladekarl M; Tabaksblat EM; Knappskog S
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
    Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
    BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology.
    van Velthuysen MF; Couvelard A; Rindi G; Fazio N; Hörsch D; Nieveen van Dijkum EJ; Klöppel G; Perren A
    J Neuroendocrinol; 2022 Mar; 34(3):e13100. PubMed ID: 35165954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
    Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme.
    Yin XN; Shen CY; Yin YQ; Chen HJ; Chen HN; Yin Y; Han LY; Chen JJ; Tang SM; Chen ZX; Zhang B
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e37-e44. PubMed ID: 28856815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
    Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
    Wang Y; Chen Y; Li X; Hu W; Zhang Y; Chen L; Chen M; Chen J
    BMC Cancer; 2018 Jun; 18(1):691. PubMed ID: 29940892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
    Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
    Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current WHO classification (2022) of neuroendocrine neoplasms].
    Buchstab O; Knösel T
    Radiologie (Heidelb); 2024 Apr; ():. PubMed ID: 38622292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment landscape of advanced high-grade neuroendocrine neoplasms.
    Alheraki SZ; Almquist DR; Starr JS; Halfdanarson TR; Sonbol MB
    Clin Adv Hematol Oncol; 2023 Jan; 21(1):16-26. PubMed ID: 36638352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET).
    Jin K; Xu J; Chen J; Chen M; Chen R; Chen Y; Chen Z; Cheng B; Chi Y; Feng ST; Fu D; Hou B; Huang D; Huang H; Huang Q; Li J; Li Y; Liang H; Lin R; Liu A; Liu J; Liu X; Lu M; Luo J; Mai G; Ni Q; Qiu M; Shao C; Shen B; Sheng W; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Tong D; Wang X; Wang J; Wang J; Wang W; Wang W; Wang Y; Wu Z; Xue L; Yan Q; Yang N; Yang Y; Yang Z; Yin X; Yuan C; Zeng S; Zhang R; Yu X
    Int J Oncol; 2016 Nov; 49(5):1991-2000. PubMed ID: 27826620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.